Keytruda 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung

7680662310025 CH-66231 Konzentrat
Keytruda 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Keytruda 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Keytruda 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/09/2025
Summary of Product Characteristics
Français
26/09/2025
Summary of Product Characteristics
Italien
26/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 4294.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2020

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
66231
Drug name
Keytruda, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FF02
Authorization status
Z
Dispensing category
A
First authorization
22/02/2017
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Package details

Description (FR)
KEYTRUDA 100 mg/4 ml conc perf 100 mg 2 pce
Description (DE)
KEYTRUDA 100 mg/4 ml Konz Inf 100 mg 2 Stk
Market launch
22/02/2017
Narcotic (BTM)
No

Other package sizes (1)

KEYTRUDA conc perf 100 mg/4ml flac
None None
GTIN: 7680662310018
Not in V1